Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Background: The biomarkers of immune checkpoint inhibitors (ICIs) efficacy and safety are still urgently needed. As cytokines are easily detected and monitored in circulation, they could be used as potential predictors of response and immune-related adverse events (irAEs) for ICIs therapy. Methods:...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Irina Besu Žižak, Jelena Milovanović, Suzana Matković, Vladimir Jurišić
स्वरूप:	लेख
भाषा:	English
प्रकाशित:	Elsevier 2023-12-01
श्रृंखला:	Translational Oncology
विषय:	Metastatic melanoma patients BRAF wild type Pembrolizumab Cytokines Monitoring Outcome predictors
ऑनलाइन पहुंच:	http://www.sciencedirect.com/science/article/pii/S1936523323001857

समान संसाधन

Complete response in a patient with BRAF-mutant metastatic melanoma achieved with the multidisciplinary approach: a case report
द्वारा: Hana Garaj, और अन्य
प्रकाशित: (2024-01-01)

Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices
द्वारा: Senar Ebinç, और अन्य
प्रकाशित: (2023-09-01)

A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
द्वारा: Wu L, और अन्य
प्रकाशित: (2021-02-01)

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients
द्वारा: Katarina Mirjačić Martinović, और अन्य
प्रकाशित: (2023-04-01)

Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation–Positive Melanoma: Patient Selection and Perspectives
द्वारा: Dugan MM, और अन्य
प्रकाशित: (2024-07-01)

Clinical significance of <it>BRAF </it>mutations in metastatic melanoma
द्वारा: Polsky David, और अन्य
प्रकाशित: (2004-12-01)

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report
द्वारा: Francesca Consoli, और अन्य
प्रकाशित: (2020-07-01)

Case report: Exceptional disease progression in a 70-year-old patient: generalized melanosis and melanuria in the course of metastatic melanoma - a case study
द्वारा: Jacek Calik, और अन्य
प्रकाशित: (2024-01-01)

Case report: Concurrent intrathecal and intravenous pembrolizumab for metastatic melanoma with leptomeningeal disease
द्वारा: Xiang Dan, और अन्य
प्रकाशित: (2024-04-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
द्वारा: I. V. SAMOILENKO, और अन्य
प्रकाशित: (2017-06-01)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive <i>BRAF</i> Mutant Advanced Melanoma
द्वारा: Ernesto Rossi, और अन्य
प्रकाशित: (2023-01-01)

A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encorafenib in healthy male subjects
द्वारा: Lance Wollenberg, और अन्य
प्रकाशित: (2023-10-01)

Potential utilization of neopterin measurements in the assessment of pyrexia in metastatic melanoma treated with combined targeted therapy: a case report
द्वारा: Bartoušková Marie, और अन्य
प्रकाशित: (2020-08-01)

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab
द्वारा: Justin C. Moser, और अन्य
प्रकाशित: (2019-12-01)

Systemic therapy of skin metastatic melanoma with BRAF gene mutation
द्वारा: Yu. S. Shakh-Paronyants, और अन्य
प्रकाशित: (2023-03-01)

A Dramatic Response to Second-Line Nivolumab and Ipilimumab in BRAF-V600-Mutated Metastatic Melanoma
द्वारा: Dahlia Fedele, और अन्य
प्रकाशित: (2024-01-01)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
द्वारा: Saba S. Shaikh, और अन्य
प्रकाशित: (2022-11-01)

Melanoma: BRAFi Rechallenge
द्वारा: Christoforos S. Kosmidis, और अन्य
प्रकाशित: (2023-05-01)

Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals
द्वारा: Milena Cavic, और अन्य
प्रकाशित: (2023-04-01)

MEK inhibitors for the treatment of NRAS mutant melanoma
द्वारा: Sarkisian S, और अन्य
प्रकाशित: (2018-08-01)

The Human Melanoma Proteome Atlas—Complementing the melanoma transcriptome
द्वारा: Lazaro Hiram Betancourt, और अन्य
प्रकाशित: (2021-07-01)

Current State of Target Treatment in BRAF Mutated Melanoma
द्वारा: Enrica Teresa Tanda, और अन्य
प्रकाशित: (2020-07-01)

Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report
द्वारा: Marco Ghezzi, और अन्य
प्रकाशित: (2020-03-01)

Limbic encephalitis in metastatic malignant melanoma patient induced by PD-1 checkpoint inhibitor pembrolizumab
द्वारा: Rozala Arko, और अन्य
प्रकाशित: (2022-07-01)

Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations
द्वारा: Ahmed Temirak, और अन्य
प्रकाशित: (2025-02-01)

p53 Promotes Cytokine Expression in Melanoma to Regulate Drug Resistance and Migration
द्वारा: Pinakin Pandya, और अन्य
प्रकाशित: (2022-01-01)

Update on the treatment of BRAFmut metastatic melanoma and future perspectives
द्वारा: Peter Mohr, और अन्य
प्रकाशित: (2025-03-01)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
द्वारा: Karam Khaddour, और अन्य
प्रकाशित: (2021-06-01)

Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study
द्वारा: Igor V. Samoylenko, और अन्य
प्रकाशित: (2024-10-01)

Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanoma
द्वारा: Adi Kartolo, और अन्य
प्रकाशित: (2022-03-01)

BRAF L485–P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review
द्वारा: Simeng Zhang, और अन्य
प्रकाशित: (2023-01-01)

Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report
द्वारा: Clara So, और अन्य
प्रकाशित: (2022-05-01)

Braf protein mutation and its significancy within patients with melanoma
द्वारा: Julia Kuchnicka, और अन्य
प्रकाशित: (2022-08-01)

Treatment of Advanced Melanoma: Past, Present and Future
द्वारा: Taku Fujimura, और अन्य
प्रकाशित: (2020-09-01)

Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
द्वारा: Elodie Long-Mira, और अन्य
प्रकाशित: (2022-03-01)

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma
द्वारा: Walid Shalata, और अन्य
प्रकाशित: (2023-02-01)

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma
द्वारा: Nakul Dar, और अन्य
प्रकाशित: (2023-08-01)

Tyrosine kinase inhibitors via nasogastric tube may resolve severe ileus secondary to melanoma: A case report
द्वारा: Lena Groennendijk, और अन्य
प्रकाशित: (2022-06-01)

Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma
द्वारा: Francesco Serra, और अन्य
प्रकाशित: (2021-08-01)

Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma
द्वारा: O. I. Kit, और अन्य
प्रकाशित: (2016-06-01)